Medical Devices Australia

Australia Carrier Screening Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Australia Carrier Screening Market Industry Trends and Forecast to 2034: Segmented by (Test, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $28.5 Mn Placeholder estimate
Estimate 2025 $32.0 Mn 1.1% of the global market
Projected 2034 $90.1 Mn 181.8% Adds $58.1 Mn over 9 forecast years
CAGR 2025–2034 12.2% Faster than 65% of 173 Medical Devices markets here
Key players 5
  • Australia is 1.08% of the global market.
  • In APAC, the largest is China at $250.5 Mn.
  • Fastest growing: India at 14.4% a year.
  • Australia ranks 5th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$58.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Carrier Screening Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $28.5 Mn — —
2025 (base) $32.0 Mn +$3.5 Mn —
2026 (forecast) $35.9 Mn +$3.9 Mn +12.2%
2027 (forecast) $40.3 Mn +$4.4 Mn +25.9%
2028 (forecast) $45.2 Mn +$4.9 Mn +41.2%
2029 (forecast) $50.7 Mn +$5.5 Mn +58.5%
2030 (forecast) $56.9 Mn +$6.2 Mn +77.8%
2031 (forecast) $63.8 Mn +$6.9 Mn +99.5%
2032 (forecast) $71.6 Mn +$7.8 Mn +123.8%
2033 (forecast) $80.3 Mn +$8.7 Mn +151.2%
2034 (forecast) $90.1 Mn +$9.8 Mn +181.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $2.96 Bn
  2. North America $1.60 Bn
  3. US $1.35 Bn
  4. APAC $617.9 Mn
  5. Europe $487.3 Mn
  6. China $250.5 Mn
  7. Canada $228.6 Mn
  8. Japan $194.1 Mn
  9. Middle East $126.2 Mn
  10. Germany $112.3 Mn
  11. Latin America $116.8 Mn
  12. Brazil $83.1 Mn
  13. Italy $80.3 Mn
  14. UK $77.7 Mn
  15. France $78.2 Mn
  16. Spain $54.5 Mn
  17. Ecuador $53.9 Mn
  18. India $54.8 Mn
  19. Africa $49.4 Mn
  20. Saudi Arabia $46.3 Mn
  21. Mexico $43.9 Mn
  22. New Zealand $33.1 Mn
  23. Australia (this report) $32.0 Mn
  24. Russia $26.8 Mn
  25. South Africa $18.2 Mn
  26. UAE $15.2 Mn
  27. Egypt $9.6 Mn
  28. Philippines $6.8 Mn
  29. Hong Kong $5.5 Mn
  30. Malaysia $4.9 Mn
  31. Singapore $3.7 Mn
  32. Thailand $3.5 Mn
  33. Kenya $2.0 Mn

Report snapshot

Australia Carrier Screening Market Analysis at a glance
Market size, 2025$32.0 Mn placeholder estimate
Forecast, 2034$90.1 Mn placeholder estimate
Growth (CAGR), 2025–203412.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, condition and end user (see all)
Key playersMyriad Genetics, Inc., Natera, Invitae, Sema4 (GeneDx), Fulgent Genetics (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Carrier Screening Market Analysis Executive Summary

Carrier screening checks future parents for gene changes they could pass on, such as for cystic fibrosis or spinal muscular atrophy.

Key segments of the carrier Screening market include test (Expanded Panels and Targeted Screening) and condition (Cystic Fibrosis, SMA and Thalassemia).

Bar chart: Australia Carrier Screening market size, 2024–2034, placeholder estimates. $28.5 Mn in 2024, $32.0 Mn in 2025 and $90.1 Mn in 2034, 12.2% CAGR.
Australia Carrier Screening market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Carrier Screening Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the carrier Screening market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the carrier Screening market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the carrier Screening market.

Competitive Landscape for Carrier Screening Market in Australia

The carrier Screening market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Carrier Screening Market in Australia

Carrier Screening in Australia: rules and payment

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how carrier Screening products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Carrier Screening right now, from free public sources.

Latest research 837 papers since 2021 (worldwide)

  1. Detection of Silent Carriers of Spinal Muscular Atrophy: A Survey of Clinical Practice and Recommendations for Screening. Twin research and human genetics : the official journal of the International Society for Twin Studies, 2026
  2. [System construction and clinical practice of genetic disease carrier screening in donor sperm-assisted reproduction]. Zhonghua nan ke xue = National journal of andrology, 2026
  3. Reproductive carrier screening: perspectives for a future implementation in Germany. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V, 2026
  4. Population-specific differences in ClinVar pathogenic and likely pathogenic variants of epilepsy-associated genes between East Asian and non-finnish European populations: a nucleotide-resolved gnomAD v4.1.1 analysis. Frontiers in genetics, 2026
  5. Genetic Landscape and Carrier Screening of Deafness-Associated Genes in a Prenatal Cohort from Fujian, China. International journal of women's health, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Carrier Screening in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 3rd highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Carrier Screening market in Australia?
Placeholder estimate: about $32.0 Mn in 2025, rising to about $90.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Carrier Screening market in Australia growing?
Placeholder estimate: about 12.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Carrier Screening market report cover?
The report splits the market by test (Expanded Panels, Targeted Screening), condition (Cystic Fibrosis, SMA, Thalassemia, Fragile X) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Carrier Screening market?
Key players include Myriad Genetics, Inc., Natera, Invitae, Sema4 (GeneDx) and Fulgent Genetics.
What is driving the Carrier Screening market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the carrier Screening market.
Who regulates Carrier Screening in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How much research is published on Carrier Screening?
PubMed lists 837 papers on Carrier Screening added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Carrier Screening in Australia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Iron Supplements and the Fight Against AnaemiaIron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Australia

See all
Same topic, other categories

Related on genomics and maternal

See the topic